Paige v. AM Hospice, Inc.

CourtDistrict Court, W.D. Texas
DecidedMay 15, 2020
Docket3:19-cv-00319
StatusUnknown

This text of Paige v. AM Hospice, Inc. (Paige v. AM Hospice, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Paige v. AM Hospice, Inc., (W.D. Tex. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS EL PASO DIVISION

ANDREA PROCTER PAIGE § Plaintiff, § § vs. § No. 3:19-CV-319-PRM § AM Hospice, Inc., § Defendant.

REPORT AND RECOMMENDATION OF THE MAGISTRATE JUDGE

On this day, the Court considered Defendant AM Hospice’s “Defendant’s Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(6) and 9(b)” (ECF No. 5), filed on December 5, 2019, in the above-captioned cause, as well as Plaintiff’s Response and claim for attorney’s fees (ECF No. 6). Defendant’s Motion was referred to this Court by the Honorable Philip R. Martinez pursuant to 28 U.S.C. § 636(b)(1)(B) and Rule 1(d) of Appendix C to the Local Rules of the Western District of Texas for proposed findings of fact and recommendations on April 30, 2020. (ECF No. 17.) For the reasons that follow, the Court recommends that Defendant’s Motion be DENIED. The Court further recommends that Plaintiff’s claim for Attorney’s fees be DENIED. Background On approximately July 29, 2019, Defendant “hire[d Plaintiff] as a Director of Nursing.” (ECF No. 1:2.) On approximately August 12, 2019, “[Defendant] Employer AM Hospice Supervisor Norma Rodriguez receive[d Plaintiff’s] report that her audit of [Defendant]’s patients reveals that [Defendant] is admitting patients who do not qualify for hospice care, and then fraudulently billing Medicare for the admitted patients who do not qualify.” (Id.) At an unspecified time, Defendant “illegally harasse[d Plaintiff] for . . . her opposition [to] and [her] report[ing] of fraud.” (Id.) On approximately August 23, 2019, “AM Hospice Supervisor Rodriguez terminate[d Plaintiff].” (Id.) Defendant “had given zero disciplinary notices/actions to [Plaintiff] at or before [Plaintiff’s] termination of employment.” (Id.) On November 4, 2019, Plaintiff filed this lawsuit raising a retaliation claim under the False Claims Act (“FCA”), 31 U.S.C. § 3730(h). (ECF No. 1:3, 1-1:1.)

Discussion I. Standard Federal Rule of Civil Procedure 12(b)(6) allows a party to move to dismiss an action for failure to state a claim upon which relief can be granted. In deciding a Rule 12(b)(6) motion to dismiss for failure to state a claim, “[t]he court accepts all well-pleaded facts as true, viewing them in the light most favorable to the plaintiff.” In re Katrina Canal Breaches Litig., 495 F.3d 191, 205 (5th Cir. 2007) (internal quotation marks omitted). A complaint must contain sufficient factual matter “to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)). “A claim has facial

plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. In addition, a whistleblower complaint alleging fraud under the FCA ordinarily must meet the heightened pleading standard of Rule 9(b). “The False Claims Act is the government’s primary litigation tool for recovering losses sustained as the result of fraud.” U.S. ex rel. Marcy v. Rowan Companies, Inc., 520 F.3d 384, 388 (5th Cir. 2008). “[T]he FCA imposes civil penalties and treble damages on any person who, inter alia, ‘knowingly makes, uses, or causes to be made or used, a false record or statement material to a false or fraudulent claim.’” United States ex rel. Steury v. Cardinal Health, Inc. (“Steury I”), 625 F.3d 262, 267 (5th Cir. 2010) (quoting 31 U.S.C. § 3729(a)(1)(B)). II. Analysis As a preliminary matter, the Court notes that, although Defendant’s briefing addressed a supposed fraud claim under the general provisions of the FCA (ECF No. 5:4-6), Plaintiff’s

Complaint raises no such claim (ECF No. 1), as Plaintiff admits in her Response. (ECF No. 6:4.) Therefore, the Court does not address Defendant’s argument regarding any supposed fraud claim under the general provisions of the FCA, as no such claim exists in this case. a. Pleading standard for FCA retaliation claims Section 3730(h) of the FCA contains a provision that aims to prevent retaliation against employees who come forward with knowledge of their employer’s FCA violations. In her Complaint, Plaintiff alleges that Defendant committed retaliatory discharge in violation of this provision by terminating her employment as retaliation for her whistleblowing. (ECF No. 1:2.) Defendant argues that the heightened pleading standard of Rule 9(b) applies to Plaintiff’s

complaint. (ECF No. 5:4.) Plaintiff argues that Rule 9(b) does not apply to retaliation claims under the FCA. (ECF No. 6:4.) The Honorable Kathleen Cardone addressed this question in 2012. Guerrero v. Total Renal Care, No. EP–11–CV–449, 2012 WL 899228, at *2 (W.D. Tex. Mar. 12, 2012). In Guerrero, Judge Cardone wrote: [T]he Court must decide whether a claim for retaliatory discharge under the FCA is subject to Rule 9(b)’s pleading standard, or whether Federal Rule of Civil Procedure 8’s pleading standard governs such a claim. Rule 9(b) requires that a party alleging fraud “must state with particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. P. 9(b). In contrast, Rule 8(a) requires only “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R .Civ .P. 8(a). The Fifth Circuit has held that claims brought under the FCA are subject to Rule 9(b)’s pleading standard; however, these cases did not involve retaliation claims. See, e.g., Cardinal Health, Inc., 625 F.3d at 266; United States ex rel. Doe v. Dow Chem. Co., 343 F.3d 325, 328-9 (5th Cir. 2003). As a result, the Fifth Circuit has not explicitly held that Rule 9(b) applies to retaliation claims made pursuant to §3730(h). See Thomas v. ITT Edu. Servs., Inc., No. 11-544, 2011 WL 3490081, at *3 (E.D. La. Aug. 10, 2011). Nevertheless, “[a]ll federal circuit courts of appeal that have faced this issue have reached the conclusion that 31 U.S.C. § 3730(h) claims need only ‘meet the Rule 8(a) . . . standard.’” Id. These courts of appeal reasoned that because retaliation claims under the FCA are not dependant [sic] on allegations of fraud, Rule 9(b)’s heightened standard should not be applied. [Citations.] The Court agrees that because claims under § 3730(h), at their core, address retaliation issues and not fraud, Rule 8 should govern. The Court therefore applies the Rule 8 pleading standard articulated in Twombly and Ashcroft v. Iqbal to Plaintiff’s FCA retaliation claim.

Id. at 2-3. The Court agrees with the reasoning in Guerrero.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Federal Deposit Insurance v. Calhoun
34 F.3d 1291 (Fifth Circuit, 1994)
Robertson v. Bell Helicopter Textron, Inc.
32 F.3d 948 (Fifth Circuit, 1994)
Edwards v. General Motors Corp.
153 F.3d 242 (Fifth Circuit, 1998)
Procter & Gamble Co v. Amway Corporation, e
280 F.3d 519 (Fifth Circuit, 2002)
Sealed 1 v. Sealed 1
156 F. App'x 630 (Fifth Circuit, 2005)
US EX REL. SANCHEZ v. Lymphatx, Inc.
596 F.3d 1300 (Eleventh Circuit, 2010)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Federal Deposit Insurance Corporation v. Conner
20 F.3d 1376 (Fifth Circuit, 1994)
In Re Katrina Canal Breaches Litigation
495 F.3d 191 (Fifth Circuit, 2007)
Shelley Thomas v. ITT Educational Services, Inc.
517 F. App'x 259 (Fifth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Paige v. AM Hospice, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/paige-v-am-hospice-inc-txwd-2020.